WebDec 21, 2024 · Baltimore, Maryland, December 21, 2024 -- Lupin Pharmaceuticals Inc. is voluntarily recalling four (4) lots of Quinapril Tablets to the patient (consumer/user) level due to the presence of a nitrosamine impurity, N-Nitroso-Quinapril, observed in recent testing above the Acceptable Daily Intake (ADI) level. To date, Lupin has received no …
FDA Update: Quinapril and Hydrochlorothiazide Tablets, USP Recall ...
WebMar 1, 2024 · Lupin recalled 4 lots of quinapril in December 2024 due to the presence of a nitrosamine impurity. Additional information can be found at … WebJan 29, 2014 · Hyderabad: Pharma firm Lupin has said its US subsidiary Lupin Pharmaceuticals Inc has initiated voluntary recall of multiple lots of Quinapril Tablets … hawthorne retirement community
Lupin recalls Quinapril tablets from US market - The Economic …
WebDec 22, 2024 · VOLUNTARILY RECALLING FOUR LOTS OF QUINAPRIL TABLETS TO PATIENT LEVEL. RECALL DUE TO PRESENCE OF NITROSAMINE IMPURITY, N … WebDec 24, 2024 · Lupin stopped marketing the medication in September and is notifying businesses of the recall. In October, Aurobindo Pharma recalled two lots of Quinapril because of the same nitrosamine impurity. WebDec 27, 2024 · Quinapril is a treatment of hypertension and lowers blood pressure. Lupin distributed the affected tablets nationwide in the United States to wholesalers, drug chains, mail order pharmacies and supermarkets, the quinapril recall states. To date, Lupin has received no reports of illness that appear to relate to this issue. hawthorne restaurant yeadon